These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of activated charcoal in a simulated poisoning with acetaminophen: a new loading dose for N-acetylcysteine? Chamberlain JM, Gorman RL, Oderda GM, Klein-Schwartz W, Klein BL. Ann Emerg Med; 1993 Sep; 22(9):1398-402. PubMed ID: 8363113 [Abstract] [Full Text] [Related]
28. Advantage of high-surface-area charcoal for gastrointestinal decontamination in a human acetaminophen ingestion model. Roberts JR, Gracely EJ, Schoffstall JM. Acad Emerg Med; 1997 Mar; 4(3):167-74. PubMed ID: 9063541 [Abstract] [Full Text] [Related]
29. Effect of Activated Charcoal on Rivaroxaban Complex Absorption. Ollier E, Hodin S, Lanoiselée J, Escal J, Accassat S, De Magalhaes E, Basset T, Bertoletti L, Mismetti P, Delavenne X. Clin Pharmacokinet; 2017 Jul; 56(7):793-801. PubMed ID: 27910037 [Abstract] [Full Text] [Related]
30. Prevention of drug absorption in simulated theophylline overdose. Minton NA, Glucksman E, Henry JA. Hum Exp Toxicol; 1995 Feb; 14(2):170-4. PubMed ID: 7779441 [Abstract] [Full Text] [Related]
31. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion. Laine K, Kivistö KT, Ojala-Karlsson P, Neuvonen PJ. Ther Drug Monit; 1997 Feb; 19(1):46-50. PubMed ID: 9029746 [Abstract] [Full Text] [Related]
32. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. Laine K, Kivistö KT, Laakso I, Neuvonen PJ. Br J Clin Pharmacol; 1997 Jan; 43(1):29-33. PubMed ID: 9056049 [Abstract] [Full Text] [Related]
34. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose. Mayersohn M, Perrier D, Picchioni AL. Clin Toxicol; 1977 Dec; 11(5):561-7. PubMed ID: 608318 [Abstract] [Full Text] [Related]
35. Effect of activated charcoal on aspirin absorption in man. Part I. Levy G, Tsuchiya T. Clin Pharmacol Ther; 1972 Dec; 13(3):317-22. PubMed ID: 5026372 [No Abstract] [Full Text] [Related]
37. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Neuvonen PJ, Elfving SM, Elonen E. Eur J Clin Pharmacol; 1978 May 31; 13(3):213-8. PubMed ID: 668776 [Abstract] [Full Text] [Related]
38. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose. Yeates PJ, Thomas SH. Br J Clin Pharmacol; 2000 Jan 31; 49(1):11-4. PubMed ID: 10606832 [Abstract] [Full Text] [Related]
39. Absorption of salicylate powders versus tablets following overdose: a poison center observational study. Rose SR, Cumpston KL, Kim J, Difranco D, Wills BK. Clin Toxicol (Phila); 2016 Nov 31; 54(9):857-861. PubMed ID: 27383649 [Abstract] [Full Text] [Related]
40. The effect of activated charcoal on N-acetylcysteine absorption in normal subjects. Ekins BR, Ford DC, Thompson MI, Bridges RR, Rollins DE, Jenkins RD. Am J Emerg Med; 1987 Nov 31; 5(6):483-7. PubMed ID: 3663288 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]